Followers | 119 |
Posts | 10891 |
Boards Moderated | 1 |
Alias Born | 11/27/2015 |
Thursday, October 11, 2018 7:38:09 PM
I am expecting a huge amount of investors to this board in the next couple of weeks so I wanted to give you an easy list of all the useful links you may want to know.
Here is a quick link to Oncbiomunes' Pipeline:
http://oncbiomune.com/pipeline/
Here is a quick link to the latest press releases:
http://oncbiomune.com/news/
Proscavax has the most potential in the pipeline and will be starting Phase 2 clinical trials at BIDMC (Harvard Medical) and UCNT (Urinary Clinic of North Texas):
https://clinicaltrials.gov/ct2/show/NCT02058680?term=oncbiomune&rank=2
https://clinicaltrials.gov/ct2/show/NCT03579654
Soon the study will be listed here:
https://www.bidmc.org/centers-and-departments/cancer-center/cancer-center-programs-and-services/genitourinary-cancer-program/genitourinary-cancer-clinical-trials
and Possibly here:
https://urologyclinics.com/about_us/clinical.html#!/study/47
If you would like to check out their patents check out this message with links:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=142315563
They were listed at OTCQB, but due to acquiring and then retracting a deal with Vitel this resulted in a most likely temporary downgrade to Pink, I'm expecting the up-listing back to OTCQB soon.
https://www.otcmarkets.com/stock/OBMP/overview
Hopefully everyone does their own DD as well and can see the value and potential that I see in this.
GO OBMP$
$OBMP
$OBMP
$OBMP
Recent THER News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:29:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/20/2024 08:35:09 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 02/15/2024 10:28:54 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 02/15/2024 08:00:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/03/2024 01:10:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 11:28:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 11:17:03 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 12/29/2023 04:26:15 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 09:51:04 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM